Why VIR? Vir Biotechnology, Inc. Analysis, Price & AI Insights | Whystock
VIR
$10.18+0.18 (+1.80%)
Market ClosedLast close May 4
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.